Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01235702 · ClinicalTrials.gov registry record · Phase 1
Metro Atlanta Heart Disease Study - II (MAHDS II)
A Phase 1 study, sponsored by Morehouse School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 210
- Enrollment target
NCT01235702 is a Phase 1 study that has completed, run by Morehouse School of Medicine. The registered enrollment target is 210 participants.
The verdict
NCT01235702, a Phase 1 study, has completed, sponsored by Morehouse School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 210 participants
- Enrollment target
Study Summary
A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized that treatment group would experience significant improvements when compared to the control group.
Interventions
- BEHAVIORAL 12-week lifestyle modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2002-09 |
| Est. Completion | 2003-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01235702
The ClinicalTrials.gov registry entry for NCT01235702 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Morehouse School of Medicine, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 12-week lifestyle modification is the first listed.
NCT01235702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01235702 about?
NCT01235702 is a clinical study titled "Metro Atlanta Heart Disease Study - II (MAHDS II)". A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized ...
What is the current status of trial NCT01235702?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 210 participants. The study started on 2002-09. Estimated completion is 2003-10.
What interventions are being tested in trial NCT01235702?
The interventions under investigation include: 12-week lifestyle modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT01235702?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.